Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000899140-22-000356
Filing Date
2022-02-17
Accepted
2022-02-17 15:29:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G m50649844.htm SC 13G 36308
  Complete submission text file 0000899140-22-000356.txt   37591
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Subject) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92206 | Film No.: 22647752
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8 SHLINKA ST RISHON LE ZION L3 75451
Business Address
Malnik Dov (Filed by) CIK: 0001912022 (see all company filings)

Type: SC 13G